Literature DB >> 26435433

Selective strategy for intensive monitoring after pheochromocytoma resection.

Cassandre E Bénay1, Mehdi Tahiri1, Lawrence Lee2, Evangelia Theodosopoulos1, Amin Madani2, Liane S Feldman2, Elliot J Mitmaker3.   

Abstract

BACKGROUND: Guidelines recommend 24-48 hours of intensive monitoring after resection of pheochromocytoma. However, many patients do not require it. The objective of this study is to identify preoperative risk factors associated with postoperative hemodynamic instability (HDI) so as to select patients who may not require intensive postoperative monitoring.
METHODS: Medical records of patients undergoing pheochromocytoma resection over a 12-year period were reviewed. Postoperative HDI was defined as systolic blood pressure of >200 or <90, heart rate >110 or <50 or needing active resuscitation.
RESULTS: We included 41 patients; 49% had postoperative HDI but only 34% had HDI > 6 hours. Risk factors for HDI were preoperative mean arterial pressure (MAP) > 100 mm Hg (14% vs 45%), norepinephrine/normetanephrine levels >3x normal (44 vs 82%), and resection of another solid organ (0 vs 20%). Avoidance of planned postoperative monitoring for low-risk patients would have reduced estimated costs by 34%.
CONCLUSION: Fewer than one-half of patients undergoing resection for pheochromocytoma benefit from intensive monitoring. High preoperative MAP, high norepinephrine/normetanephrine levels, and concomitant resection of another organ are risk factors for postoperative HDI. After a 6-hour interval of postoperative stability, selective rather than routine use of intensive monitoring may be an efficient strategy for monitoring lower risk patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26435433     DOI: 10.1016/j.surg.2015.06.045

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  PATIENTS' SAFETY AND FEASIBILITY OF INTRAVENOUS URAPIDIL IN THE PRETREATMENT OF PHEOCHROMOCYTOMA PATIENTS IN A NORMAL WARD SETTING - AN ANALYSIS OF 20 CONSECUTIVE CASES.

Authors:  A Reinisch; K Holzer; J Bojunga; W O Bechstein; N Habbe
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

Review 2.  Current perioperative management of pheochromocytomas.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Indian J Urol       Date:  2017 Jan-Mar

3.  Changes in blood pressure, blood sugar, and quality of life in patients undergoing pheochromocytoma surgery: a prospective cohort study.

Authors:  Pradeep Prakash; Rashmi Ramachandran; Nikhil Tandon; Rajeev Kumar
Journal:  Indian J Urol       Date:  2019 Jan-Mar

4.  Incidence, risk factors and clinical significance of postoperative haemodynamic instability after adrenalectomy for phaeochromocytoma.

Authors:  Joseph P Thompson; Davinia Bennett; James Hodson; Miriam Asia; John Ayuk; Michael W O'Reilly; Niki Karavitaki; Wiebke Arlt; Robert P Sutcliffe
Journal:  Gland Surg       Date:  2019-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.